encorafenib,binimetinib
pfizer,ono pharma,pierre fabre
['lung', 'nsclc', 'lcsm,(-blcsm)', 'binimetinib', 'encorafenib', 'sclc']
our own of describes the results of a prospective trial of encorafenib and binimetinib for people with rafv600e-mutant metastatic non-small cell #lungcancer. read the paper here: #nsclc #lcsm #asco23 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag